PROTECTIVE AND THERAPEUTIC IMMUNITY TO PAPILLOMATOSIS
PROTECTIVE AND THERAPEUTIC IMMUNITY TO PAPILLOMATOSIS
批准号:
3202258
负责人:
JANET L BRANDSMA
金额:
$28.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-07-15 至 1996-04-30
关键词:
active immunization delayed hypersensitivity disease /disorder model genetic manipulation laboratory rabbit molecular cloning neoplasm /cancer immunology neoplasm /cancer immunotherapy nonhuman therapy evaluation open reading frames polymerase chain reaction rabbit papillomavirus recombinant DNA transfection /expression vector viral vaccines virus DNA virus antigen virus protein virus related neoplasm /cancer
中文摘要
人乳头瘤病毒(HPV)与这种疾病的发生密切相关。
宫颈癌和其他肛门生殖器癌。治疗
癌前病变并不是对所有患者都有效。自发
回归是常见的,但不是普遍的,而且可能在几年内不会发生。
已有报道对许多HPV蛋白具有免疫活性。因此
接种HPV疫苗有望预防癌前病变
发展、诱导或加速它们的退化。疫苗
研发最初不能依赖于临床实验,因为
识别HPV阴性受试者的困难在于
过多的HPV类型,以及癌前病变的复发和
HPV再感染很常见。此外,已经不可能
在感染HPV的动物中诱发疾病。人乳头瘤病毒的最佳动物模型
发展为癌症的疾病是棉尾兔乳头瘤病毒
(CRPV)感染实验兔。我们建议利用CRPV
开发光伏疫苗的模式。初步实验将识别CRPV
编码诱导免疫的蛋白质的基因,这种免疫可以防止
乳头状瘤形成或诱导乳头状瘤消退。后续
实验将评估相应的HPV基因的能力,
在重组CRPV病毒中表达,以诱导保护性或
治疗性免疫。一旦确定了有效的光伏疫苗,他们的
尽可能直接的抗癌疫苗的价值可以使用测试,用于
例如,CRPV或CRPV/HPV诱导的可移植兔癌
以重组体为模型靶点。
英文摘要
Human papillomaviruses (HPVs) are strongly implicated in the development
of cervical carcinoma and other anogenital cancers. Treatment of
precancerous lesions is not effective in all patients. Spontaneous
regression is common but not universal, and may not occur for years.
Immune activity to a number of HPV proteins has been reported. Therefore
vaccination to HPV holds promise for preventing precancerous lesions from
developing or inducing or accelerating their regression. Vaccine
development cannot rely initially on clinical experimentation because of
the difficulties in identifying HPV-negative subjects because of the
plethora of HPV types, and because recurrence of precancerous lesions and
HPV reinfection are common. In addition, it has been impossible to
induce disease in animals with HPVs. The best animal model for HPV
disease that progresses to cancer is cottontail rabbit papillomavirus
(CRPV) infection of laboratory rabbits. We propose to utilize the CRPV
model to develop PV vaccines. Initial experiments will identify CRPV
genes coding for proteins that elicit immunity which protects against
papilloma formation or induces papilloma regression. Subsequent
experiments will evaluate the ability of corresponding HPV genes,
expressed in recombinant CRPV viruses, to elicit protective or
therapeutic immunity. Once effective PV vaccines are identified, their
value as possible direct anti-cancer vaccines can be tested using, for
example, transplantable rabbit carcinomas induced by CRPV or CRPV/HPV
recombinants as model targets.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Langerhans cell-mediated immune modulation of HPV8 expression and tumorgenesis
-
批准号:7530393
-
项目类别:
-
资助金额:$18.62万
-
财政年份:2008
-
负责人:JANET L BRANDSMA
-
依托单位:
Langerhans cell-mediated immune modulation of HPV8 expression and tumorgenesis
-
批准号:7624197
-
项目类别:
-
资助金额:$22.34万
-
财政年份:2008
-
负责人:JANET L BRANDSMA
-
依托单位:
Papillomavirus E2 as a cervical/anal cancer drug target
-
批准号:6915013
-
项目类别:
-
资助金额:$24.53万
-
财政年份:2004
-
负责人:JANET L BRANDSMA
-
依托单位:
Papillomavirus E2 as a cervical/anal cancer drug target
-
批准号:6844396
-
项目类别:
-
资助金额:$23.39万
-
财政年份:2004
-
负责人:JANET L BRANDSMA
-
依托单位:
VSV-based Therapeutic Papilloma Vaccine
-
批准号:6761813
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2003
-
负责人:JANET L BRANDSMA
-
依托单位:
VSV-based Therapeutic Papilloma Vaccine
-
批准号:6679199
-
项目类别:
-
资助金额:$31.66万
-
财政年份:2003
-
负责人:JANET L BRANDSMA
-
依托单位:
VSV-based Therapeutic Papilloma Vaccine
-
批准号:7226737
-
项目类别:
-
资助金额:$31.04万
-
财政年份:2003
-
负责人:JANET L BRANDSMA
-
依托单位:
VSV-based Therapeutic Papilloma Vaccine
-
批准号:7060357
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2003
-
负责人:JANET L BRANDSMA
-
依托单位:
VSV-based Therapeutic Papilloma Vaccine
-
批准号:6897543
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2003
-
负责人:JANET L BRANDSMA
-
依托单位:
CTL responses to vaccination in CRPV rabbit model
-
批准号:6445484
-
项目类别:
-
资助金额:$7.23万
-
财政年份:2001
-
负责人:JANET L BRANDSMA
-
依托单位:
GENETIC DETERMINANTS OF HUMAN PAPILLOMAVIRUS PATHOGENICITY
-
批准号:6268828
-
项目类别:
-
资助金额:$16.76万
-
财政年份:1998
-
负责人:JANET L BRANDSMA
-
依托单位:
GENETIC DETERMINANTS OF HUMAN PAPILLOMAVIRUS PATHOGENICITY
-
批准号:6236233
-
项目类别:
-
资助金额:$16.14万
-
财政年份:1997
-
负责人:JANET L BRANDSMA
-
依托单位:
PROTECTIVE AND THERAPEUTIC IMMUNITY TO PAPILLOMATOSIS
-
批准号:3202259
-
项目类别:
-
资助金额:$28.83万
-
财政年份:1992
-
负责人:JANET L BRANDSMA
-
依托单位:
PROTECTIVE AND THERAPEUTIC IMMUNITY TO PAPILLOMATOSIS
-
批准号:2098672
-
项目类别:
-
资助金额:$29.38万
-
财政年份:1992
-
负责人:JANET L BRANDSMA
-
依托单位:
PROTECTIVE AND THERAPEUTIC IMMUNITY TO PAPILLOMATOSIS
-
批准号:2098673
-
项目类别:
-
资助金额:$31.34万
-
财政年份:1992
-
负责人:JANET L BRANDSMA
-
依托单位:
CTL responses to vaccination in CRPV rabbit model
-
批准号:6318510
-
项目类别:
-
资助金额:$7.23万
-
财政年份:1992
-
负责人:JANET L BRANDSMA
-
依托单位:
STUDIES IN VIVO OF PAPILLOMAVIRUS TRANSFORMING GENES
-
批准号:3423644
-
项目类别:
-
资助金额:$8.4万
-
财政年份:1991
-
负责人:JANET L BRANDSMA
-
依托单位:
VIVO OF PAPILLOMAVIRUS TRANSFORMING GENES
-
批准号:3423645
-
项目类别:
-
资助金额:$8.2万
-
财政年份:1991
-
负责人:JANET L BRANDSMA
-
依托单位:
CANCER OF THE HEAD & NECK--EPIDEMIOLOGY AND BIOCHEMISTRY
-
批准号:3177913
-
项目类别:
-
资助金额:$13.04万
-
财政年份:1985
-
负责人:JANET L BRANDSMA
-
依托单位:
CANCER OF THE HEAD & NECK--EPIDEMIOLOGY AND BIOCHEMISTRY
-
批准号:3177914
-
项目类别:
-
资助金额:$14.02万
-
财政年份:1985
-
负责人:JANET L BRANDSMA
-
依托单位:
海外基金